Colchicine-derived compound CT20126 promotes skin allograft survival by regulating the balance of Th1 and Th2 cytokine production

Seon Jin Lee, Seung Namkoong, Kwon Soo Ha, Woo Dong Nam, Young-Guen Kwon, Hansoo Lee, Eun Young Yoon, Dong Jo Chang, Soon Ok Kim, Young Myeong Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Colchicine has been shown to regulate the expression of inflammatory gene, but this compound possesses much weaker anti-inflammatory activity. In this study, we synthesized a new colchicine derivative CT20126 and examined its immunomodulatory property. CT20126 was found to have immunosuppressive effects by inhibiting lymphocyte proliferation without cytotoxicity and effectively inhibit the transcriptional expression of the inflammatory genes, iNOS, TNF-α, and IL-1β, in macrophages stimulated by LPS. This effect was nearly comparable to that of cyclosporine A. This compound also significantly suppressed the production of nitric oxide and Th1-related pro-inflammatory cytokines, IL-1β, TNF-α, and IL-2, with minimal suppression of Th2-related anti-inflammatory cytokines IL-4 and IL-10 in the sponge matrix allograft model. Moreover, administration of CT20126 prolonged the survival of allograft skins from BALB/c mice (H-2d) to the dorsum of C57BL/6 (H-2b) mice. The in vivo immune suppressive effects of CT20126 were similar to that of cyclosporine A. These results indicate that this compound may have potential therapeutic value for transplantation rejection and other inflammatory diseases.

Original languageEnglish
Pages (from-to)230-238
Number of pages9
JournalExperimental and Molecular Medicine
Volume39
Issue number2
DOIs
Publication statusPublished - 2007 Apr 30

Fingerprint

Th1-Th2 Balance
Colchicine
Allografts
Skin
Cytokines
Interleukin-1
Cyclosporine
Anti-Inflammatory Agents
Genes
Gene Expression
Lymphocytes
Macrophages
Graft Rejection
Porifera
Immunosuppressive Agents
Cytotoxicity
Interleukin-4
Interleukin-10
Interleukin-2
Nitric Oxide

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Lee, Seon Jin ; Namkoong, Seung ; Ha, Kwon Soo ; Nam, Woo Dong ; Kwon, Young-Guen ; Lee, Hansoo ; Yoon, Eun Young ; Chang, Dong Jo ; Kim, Soon Ok ; Kim, Young Myeong. / Colchicine-derived compound CT20126 promotes skin allograft survival by regulating the balance of Th1 and Th2 cytokine production. In: Experimental and Molecular Medicine. 2007 ; Vol. 39, No. 2. pp. 230-238.
@article{cca70755256b402da4828686be589048,
title = "Colchicine-derived compound CT20126 promotes skin allograft survival by regulating the balance of Th1 and Th2 cytokine production",
abstract = "Colchicine has been shown to regulate the expression of inflammatory gene, but this compound possesses much weaker anti-inflammatory activity. In this study, we synthesized a new colchicine derivative CT20126 and examined its immunomodulatory property. CT20126 was found to have immunosuppressive effects by inhibiting lymphocyte proliferation without cytotoxicity and effectively inhibit the transcriptional expression of the inflammatory genes, iNOS, TNF-α, and IL-1β, in macrophages stimulated by LPS. This effect was nearly comparable to that of cyclosporine A. This compound also significantly suppressed the production of nitric oxide and Th1-related pro-inflammatory cytokines, IL-1β, TNF-α, and IL-2, with minimal suppression of Th2-related anti-inflammatory cytokines IL-4 and IL-10 in the sponge matrix allograft model. Moreover, administration of CT20126 prolonged the survival of allograft skins from BALB/c mice (H-2d) to the dorsum of C57BL/6 (H-2b) mice. The in vivo immune suppressive effects of CT20126 were similar to that of cyclosporine A. These results indicate that this compound may have potential therapeutic value for transplantation rejection and other inflammatory diseases.",
author = "Lee, {Seon Jin} and Seung Namkoong and Ha, {Kwon Soo} and Nam, {Woo Dong} and Young-Guen Kwon and Hansoo Lee and Yoon, {Eun Young} and Chang, {Dong Jo} and Kim, {Soon Ok} and Kim, {Young Myeong}",
year = "2007",
month = "4",
day = "30",
doi = "10.1038/emm.2007.26",
language = "English",
volume = "39",
pages = "230--238",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "2",

}

Colchicine-derived compound CT20126 promotes skin allograft survival by regulating the balance of Th1 and Th2 cytokine production. / Lee, Seon Jin; Namkoong, Seung; Ha, Kwon Soo; Nam, Woo Dong; Kwon, Young-Guen; Lee, Hansoo; Yoon, Eun Young; Chang, Dong Jo; Kim, Soon Ok; Kim, Young Myeong.

In: Experimental and Molecular Medicine, Vol. 39, No. 2, 30.04.2007, p. 230-238.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Colchicine-derived compound CT20126 promotes skin allograft survival by regulating the balance of Th1 and Th2 cytokine production

AU - Lee, Seon Jin

AU - Namkoong, Seung

AU - Ha, Kwon Soo

AU - Nam, Woo Dong

AU - Kwon, Young-Guen

AU - Lee, Hansoo

AU - Yoon, Eun Young

AU - Chang, Dong Jo

AU - Kim, Soon Ok

AU - Kim, Young Myeong

PY - 2007/4/30

Y1 - 2007/4/30

N2 - Colchicine has been shown to regulate the expression of inflammatory gene, but this compound possesses much weaker anti-inflammatory activity. In this study, we synthesized a new colchicine derivative CT20126 and examined its immunomodulatory property. CT20126 was found to have immunosuppressive effects by inhibiting lymphocyte proliferation without cytotoxicity and effectively inhibit the transcriptional expression of the inflammatory genes, iNOS, TNF-α, and IL-1β, in macrophages stimulated by LPS. This effect was nearly comparable to that of cyclosporine A. This compound also significantly suppressed the production of nitric oxide and Th1-related pro-inflammatory cytokines, IL-1β, TNF-α, and IL-2, with minimal suppression of Th2-related anti-inflammatory cytokines IL-4 and IL-10 in the sponge matrix allograft model. Moreover, administration of CT20126 prolonged the survival of allograft skins from BALB/c mice (H-2d) to the dorsum of C57BL/6 (H-2b) mice. The in vivo immune suppressive effects of CT20126 were similar to that of cyclosporine A. These results indicate that this compound may have potential therapeutic value for transplantation rejection and other inflammatory diseases.

AB - Colchicine has been shown to regulate the expression of inflammatory gene, but this compound possesses much weaker anti-inflammatory activity. In this study, we synthesized a new colchicine derivative CT20126 and examined its immunomodulatory property. CT20126 was found to have immunosuppressive effects by inhibiting lymphocyte proliferation without cytotoxicity and effectively inhibit the transcriptional expression of the inflammatory genes, iNOS, TNF-α, and IL-1β, in macrophages stimulated by LPS. This effect was nearly comparable to that of cyclosporine A. This compound also significantly suppressed the production of nitric oxide and Th1-related pro-inflammatory cytokines, IL-1β, TNF-α, and IL-2, with minimal suppression of Th2-related anti-inflammatory cytokines IL-4 and IL-10 in the sponge matrix allograft model. Moreover, administration of CT20126 prolonged the survival of allograft skins from BALB/c mice (H-2d) to the dorsum of C57BL/6 (H-2b) mice. The in vivo immune suppressive effects of CT20126 were similar to that of cyclosporine A. These results indicate that this compound may have potential therapeutic value for transplantation rejection and other inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=34247645082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247645082&partnerID=8YFLogxK

U2 - 10.1038/emm.2007.26

DO - 10.1038/emm.2007.26

M3 - Article

VL - 39

SP - 230

EP - 238

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 2

ER -